Processus Wealth & Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
Processus Wealth & Capital Management's TMO Position: Q3 2026 in Review
Processus Wealth & Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 18% in Q3 2026, selling an estimated $646K and leaving 4,818 shares worth $3.25M. The position accounts for 1.89% of the portfolio, ranked #21.
Processus Wealth & Capital Management first reported a position in TMO in Q4 2023 and has held it in 12 quarters since. The position peaked at $3.79M in Q4 2025. 2,797 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Processus Wealth & Capital Management held 4,818 shares of Thermo Fisher Scientific worth $3.25M as of Q3 2026.
- Processus Wealth & Capital Management sold 1,088 Thermo Fisher Scientific shares in Q3 2026, an estimated $646K.
- Thermo Fisher Scientific made up 1.89% of Processus Wealth & Capital Management's portfolio in Q3 2026, its #21 holding.
- Processus Wealth & Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 12 quarters since.
- Processus Wealth & Capital Management's Thermo Fisher Scientific position peaked at $3.79M in Q4 2025.
- 2,797 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Processus Wealth & Capital Management's 13F filing for Q3 2026, filed 16 Oct 2026.